Allarity Therapeutics, Inc. Stock Nasdaq Stockholm
Equities
ALLR
US0167441049
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 5.2M 55.12M 7.12M |
---|---|---|---|---|---|
Net income 2024 * | -16M -169M -21.88M | Net income 2025 * | -28M -297M -38.28M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.08
x | P/E ratio 2025 * |
-0.13
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 100% |
Latest transcript on Allarity Therapeutics, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Thomas Jensen
FOU | Founder | 45 | 20-05-31 |
Joan Brown
DFI | Director of Finance/CFO | 71 | 21-09-20 |
Chief Tech/Sci/R&D Officer | 63 | 21-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 56 | 22-09-30 | |
Thomas Jensen
FOU | Founder | 45 | 20-05-31 |
Joseph Vazzano
BRD | Director/Board Member | 40 | 23-07-31 |
1st Jan change | Capi. | |
---|---|---|
+20.17% | 126B | |
+24.67% | 118B | |
+25.44% | 27.87B | |
-17.74% | 20.95B | |
-15.17% | 16.92B | |
-15.21% | 16.18B | |
+11.91% | 14.84B | |
-47.10% | 14.79B | |
+54.50% | 14.08B |